FDA adviser who stepped down over Alzheimer's drug approval says there's no "good evidence that it works"

Posted on AllSides June 21st, 2021
From The Left

A member of the FDA advisory committee who stepped down after the regulating body's approval of Aduhelm, a controversial new Alzheimer's drug, claims the treatment "showed no good evidence that it worked." 

Harvard professor of medicine Dr. Aaron Kesselheim, who also works at Brigham and Women's Hospital, called it the "worst drug approval decision in recent U.S. history" in his resignation letter. 

"It had important side effects," Kesselheim told CBS News' Dr. Tara Narula. "The FDA's totally switching gears over the last six months, and approving this drug on the basis of...

Read full story

More News about Public Health from the Left, Center and Right

From the Left

From the Center

From the Right